Search for: "Merck & Company, Inc."
Results 321 - 340
of 446
Sorted by Relevance
|
Sort by Date
5 Jan 2022, 4:33 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S.Ct. 2786, 125 L.Ed.2d 469 (1993).Where does the universe of disability terminate? [read post]
8 Mar 2019, 5:00 am
Their argument cited ongoing litigation in Mondelez International, Inc. v. [read post]
13 Dec 2015, 4:01 pm
.* LG Mannheim: there is no German balsamicoMark reports on an interesting (and quite astonishing) German decision addressing the possible infringement of the “Aceto Balsamico di Modena” geographical indication by a German company using “Balsamico” vinegar.* Are the DTSA's ex parte seizure powers the Anton Piller Order's evil American cousin? [read post]
12 Jul 2012, 11:17 am
Inc. over .merck; e. [read post]
21 Mar 2007, 1:05 am
ALM Privacy Policy / Contact Us
© 2007 ALM Properties, Inc. [read post]
21 Mar 2007, 1:05 am
ALM Privacy Policy / Contact Us
© 2007 ALM Properties, Inc. [read post]
6 Feb 2022, 9:01 pm
Sponsored by: MERCK Animal Health. 2021 Recipient: Melanie J. [read post]
29 Feb 2016, 4:43 pm
Taylor, 782 F.3d 1142 (10th Cir. 2015); In re Merck & Co., Inc. [read post]
22 Apr 2010, 3:51 am
Paddock Laboratories, Inc. [read post]
2 Aug 2010, 1:25 am
Merck & Co. [read post]
20 Dec 2023, 5:00 am
Monoclonal Antibodies Inc., 1985) protected large genus claims. [read post]
25 Aug 2008, 10:55 am
Wyeth, Inc., 2006 WL 462470 (N.J. [read post]
11 Aug 2021, 7:00 am
” Addressing NOVAD’s argument that a previous decision, Merck and Company, Inc., B-295888 (May 13, 2005), was similar to the matter at hand, GAO explained: “In that decision, we concluded a statute establishing a process for an agency to make formulary decisions concerning which pharmaceutical agents to make available to beneficiaries was a procurement statute because agency decisions made under the statute would lead directly to the purchase of… [read post]
8 Feb 2011, 10:51 pm
(FDA Law Blog) US: Another academic with solutions to problems that don’t exist (Patent Docs) US: Syngenta files for declaratory judgment of invalidity and non-infringement of Bayer’s patents based on its development of GM crops containing HPPD gene (Patent Docs) US: District Court New Jersey: Loss of market share to infringing competitor during six year reexamination warrants denial of stay: Wyeth et al v Abbott (Docket Report) US: District Court New Jersey: Court precludes jury… [read post]
22 Jan 2008, 4:30 am
Merck & Company, Inc., the court examined the change in the class representative. [read post]
9 Mar 2011, 3:00 am
Allergan, Inc (Chicago IP Litigation Blog) Synagis (Palivizumab) – US: PDL BioPharma settles Medimmune Synagis litigation for $93M (Patent Docs) TriCor (Fenofibrate) – US: Abbott and Elan end TriCor suit with Ranbaxy (Patent Docs) Valsartan – Norway: Oslo District Court holds Actavis’ Valsartan/HCTZ product infringes Novartis’ patent covering synthesis route for Valsartan; deals inter alia with scope of Valsartan SPC (The SPC Blog) [read post]
10 Jan 2011, 8:00 am
In the reply brief, Petitioners asserted that: In this case, the handful of adverse event reports (“AERs”) Matrixx Initiatives, Inc. [read post]
31 Dec 2009, 4:43 pm
------- Title: Merck & Co., Inc. v. [read post]
19 Sep 2013, 9:53 am
By itself, off-label promotion is no more causal than, as we commented the other day, a “video of a company employee kicking his dog. [read post]
1 Mar 2010, 7:11 pm
Blistex, Ciba, Pfizer, 3M, Edgecraft, Darex, Cisco, Bunn-O-Matic, Oreck, Novartis, Merck, etc. [read post]
